Skip to content

Comparing the single-spin and double-spin PRP in the treatment of hair loss

Comparative Evaluation of Single-Spin with Double-Spin Platelet-Rich Plasma in the Treatment of Androgenic Alopecia: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108782
Enrollment
24
Registered
2026-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z768- Persons encountering health services in other specified circumstances

Interventions

Intervention1: Study Group 2 (Group B): In this group, PRP will be prepared using the double-spin technique. Approximately 9 mL of venous blood will be drawn and placed into a tube containing 1 mL of

Sponsors

GEETANJALI DENTAL RESEARCH INSTITUTE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male Patients above the age of 18 years. 1 Type I and Type II Patients indicated for the management of androgenic Alopecia as per Bouhanna s classification for male. 2 Healthy patients falling under ASA I and ASA II 3 Subjects able and willing to provide written informed consent and compliant with study procedure.

Exclusion criteria

Exclusion criteria: 1 Patients who had not received any topical or systemic treatment for their hair loss during the last 3 months 2 Patient with history of having anticoagulant therapy 3 Patients having history of autoimmune disorder, haematological disorder and platelet dysfunction syndrome. 4 Patients with a history of immunosuppression (malignancy, chemotherapy, steroid therapy), dermatological acute infections and diseases other than androgenic alopecia affecting the scalp. 5 Patient is under regular analgesics and anti-depressants. 6 Having previous history of radiation therapy in the head and neck region. 7 Patients with a history of hair transplant. 8 Patient having tendency for the hypertrophic scar and keloid formation. 9 Patient who has already received single spin PRP and double spin PRP treatment for more than 3 sittings within 3 months 10 Patients with the history of immunodeficiency virus (HIV, hepatitis B and hepatitis C)

Design outcomes

Primary

MeasureTime frame
Hair-pull test Hair density with the help of trichoscope Timepoint: 1st, 2nd, 3rd, 4th month

Secondary

MeasureTime frame
Patient satisfaction Investigator satisfaction Any other complications if arise, will be notedTimepoint: 1st, 2nd, 3rd, 4th month

Countries

India

Contacts

Public ContactDr Nishigandha Ambre

geetanjali dental college and research institute

drshallu23@gmail.com9116155666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026